Updated:
Emles Venture Partners
Founded by serial entrepreneurs Michael Loffe, Ryan Laverty, and Maxine Anderson, Emles Venture Partners operates from New York with a founder-centric...
Emles Venture Partners
Founded by serial entrepreneurs Michael Loffe, Ryan Laverty, and Maxine Anderson, Emles Venture Partners operates from New York with a founder-centric mandate. The firm invests personal capital into seed-stage startups and maintains a commitment to follow-on rounds. Its wealth originates from the founders' own successful exits, grounding the firm's decisions in operator experience rather than institutional committee logic. Emles structures its engagement around three pillars: bridge capital for pre-Series A needs, a unique debt offering to optimize cost of capital, and investment decisions delivered within 72 hours of a first meeting. The portfolio spans AI/ML, digital health, enterprise software, agri-food tech, and edtech. Confirmed positions include 1910 Genetics, which applies computation and physics to drug development, Shiru's precision biology for food proteins, and Zeta Surgical's image-guided procedures. The firm also backs Arist, co-founded by Michael Loffe, which uses text and WhatsApp to deliver corporate training to Fortune 1000 companies and nonprofits. The firm operates from a single office at 101 Greenwich Street in New York. Its team size and total deployment are not publicly disclosed. Adjacent vehicles or philanthropic structures are not mentioned. In its own materials, Emles highlights that portfolio founders' efforts have been recognized by Forbes and won prestigious science and innovation grants. A structural differentiator lies in Emles's combination of operator capital and a strict 72-hour decision clock. The firm imposes no sector boxes or internal bureaucracy, positioning itself as an unconstrained seed investor that can act faster than institutional peers while providing structured debt and follow-on equity commitments from its own balance sheet.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
101 Greenwich St., Suite 8C, New York, NY 10006, United States
Principals
Michael Loffe
Founder
Ryan Laverty
Founder
Maxine Anderson
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Emles Venture Partners?
The firm is led by its three founders: Michael Loffe, Ryan Laverty, and Maxine Anderson. They are described as serial entrepreneurs who invest personal capital, suggesting all three are directly involved in deal evaluation and approval. No separate investment committee or external advisors are disclosed.
How does Emles Venture Partners source proprietary deal flow?
Emles invites founders to submit their business proposals directly to founder@emles.com. The firm emphasizes that it reviews every proposal and commits to a response within 72 hours. This open-access approach is complemented by the founding team's own networks as operators, though no structured outbound sourcing engine is publicly described.
Is Emles Venture Partners structured as a family office or does it operate more like a venture firm?
Emles operates as a venture firm deploying personal capital rather than a registered family office. It sources and invests like a seed-stage VC but is funded by the founders' own wealth, without external limited partners, and offers a unique mix of equity and debt from its balance sheet.
What investment stages does Emles Venture Partners typically target?
The firm targets seed-stage companies and supports them through subsequent growth stages. Its offering includes bridge capital for pre-Series A needs and a unique debt product. The 72-hour decision window is tailored for early-stage founders who need speed and quick access to additional capital.
Does Emles Venture Partners participate in fund commitments or only direct deals?
Emles makes only direct investments. Its model is built on using personal capital for direct equity stakes and providing its own debt facilities. There is no indication that the firm acts as a limited partner in other venture funds.
Which sectors does Emles Venture Partners explicitly avoid?
The firm does not publicly list any sectors it avoids. Its own description says it is unconstrained, with no boxes to check, no bureaucracy to defend, and a focus on 'the best ideas.' Current portfolio companies cut across AI-driven drug design, food science, surgical robotics, supply chain software, and mobile-based corporate learning.
How is Emles Venture Partners related to the named founder's operating company Arist?
Michael Loffe, one of Emles's founders, is also a co-founder of Arist, a text-message-based corporate training platform in the Emles portfolio. This creates a direct principal-to-portfolio relationship where the firm invests in and actively supports a company built by one of its own founding partners.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: